BioForce Nanosciences (OTCMKTS:BFNH) Releases Earnings Results

BioForce Nanosciences (OTCMKTS:BFNH) released its quarterly earnings results on Tuesday. The company reported ($0.03) EPS for the quarter, Zacks reports.

BioForce Nanosciences Price Performance

Shares of BFNH opened at $0.53 on Thursday. The firm has a market cap of $17.77 million, a price-to-earnings ratio of -53.00 and a beta of -0.93. The business’s 50 day moving average is $0.56 and its two-hundred day moving average is $0.70. BioForce Nanosciences has a 52-week low of $0.16 and a 52-week high of $2.07.

About BioForce Nanosciences

BioForce Nanosciences Holdings, Inc focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels.